Literature DB >> 29205267

The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.

Christopher D Gocke1, Douglas E Gladstone2.   

Abstract

Entities:  

Keywords:  chronic lymphocytic leukaemia; haematological malignancy; oncological intervention

Mesh：

Substances：

Year:  2017        PMID： 29205267     DOI： 10.1111/bjh.15015

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  1 in total

1.  Normal serum protein electrophoresis and mutated IGHV genes detect very slowly evolving chronic lymphocytic leukemia patients.

Authors:  Jasmine Chauzeix; Marie-Pierre Laforêt; Mélanie Deveza; Liam Crowther; Elodie Marcellaud; Paco Derouault; Anne-Sophie Lia; François Boyer; Nicolas Bargues; Guillaume Olombel; Arnaud Jaccard; Jean Feuillard; Nathalie Gachard; David Rizzo
Journal:  Cancer Med       Date:  2018-05-09       Impact factor: 4.452
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.